Honghai Ouyang

Title: Innovations in Cancer Diagnosis by Honghai Ouyang

Introduction

Honghai Ouyang is a notable inventor based in West Windsor, NJ (US). He has made significant contributions to the field of cancer research, particularly in the diagnosis and assessment of cancer predisposition. With a total of 2 patents, his work is paving the way for advancements in cancer diagnostics.

Latest Patents

Ouyang's latest patents focus on the uses of Ku70, a protein that plays a crucial role in tumor suppression. One of his inventions provides a method for diagnosing a predisposition to cancer by obtaining a nucleic acid sample from a subject. This method involves determining whether the subject's Ku70 alleles or regulatory regions are deleted or differ from the wild type, which may reduce or eliminate the expression of polypeptides with tumor suppressor activity. Additionally, his inventions include methods for assessing the severity of cancer by analyzing the subcellular localization of Ku70, where abnormal localization may indicate a predisposition to cancer.

Career Highlights

Honghai Ouyang is affiliated with the Sloan Kettering Institute for Cancer Research, where he continues to contribute to groundbreaking research in cancer diagnostics. His work is instrumental in developing innovative methods that could potentially change the landscape of cancer detection and treatment.

Collaborations

Ouyang collaborates with esteemed colleagues in the field, including Gloria C. Li and Carlos Cordon-Cardo. These partnerships enhance the research efforts and broaden the impact of their findings in cancer research.

Conclusion

Honghai Ouyang's innovative work in cancer diagnostics exemplifies the importance of research and invention in the medical field. His contributions are vital for improving cancer detection methods and ultimately enhancing patient outcomes.